SARC-F is a predictor of longer LOS and hospital readmission in hospitalized patients after a cardiovascular event
| dc.contributor.author | Fayh, Ana Paula Trussardi | |
| dc.contributor.author | Guedes, Francisco Felipe de Oliveira | |
| dc.contributor.author | Calado, Guilherme Carlos Filgueira | |
| dc.contributor.author | Queiroz, Sandra Azevedo | |
| dc.contributor.author | Anselmo, Marina Gabriely Gomes Barbosa | |
| dc.contributor.author | Sousa, Iasmin Matias de | |
| dc.date.accessioned | 2023-11-29T19:19:29Z | |
| dc.date.available | 2023-11-29T19:19:29Z | |
| dc.date.issued | 2022-07 | |
| dc.description.resumo | It is already established that sarcopenia is associated with adverse outcomes; however, few studies have focused on patients who have suffered an acute cardiovascular event. The use of SARC-F, a 5-item sarcopenia screening questionnaire, in these patients remains to be investigated. We aimed to investigate whether SARC-F can predict adverse outcomes in patients admitted to a hospital with a suspected infarction. This is a 1-year prospective cohort study. During hospitalization, patients completed the SARC-F questionnaire (scores ≥ 4 considered positive for the risk of sarcopenia). Length of hospital stay (LOS), new hospital admission, myocardial infarction, and cardiovascular mortality were collected via medical records and phone interviews. In total, 180 patients were evaluated. The median age was 60.6 years; 72.3% of the participants were men, and half of the sample had comorbidities. The median SARC-F score was 1.0 (interquartile range, 0–3.0), and 21.1% of the participants screened positive. Risk of sarcopenia was independently associated with longer LOS (odds ratio, 2.34; 95% CI, 1.09–5.04; p = 0.030) and hospital readmission (odds ratio, 3.73; 95% CI, 1.60–8.69; p = 0.002). One-fifth of post-acute cardiovascular event patients in this cohort screened positive for sarcopenia using the SARC-F screening questionnaire. Positive scores were associated with a longer LOS and hospital readmission | pt_BR |
| dc.identifier.citation | FAYH, Ana Paula Trussardi; GUEDES, Francisco Felipe de Oliveira; CALADO, Guilherme Carlos Filgueira; QUEIROZ, Sandra Azevedo; ANSELMO, Marina Gabriely Gomes Barbosa; SOUSA, Iasmin Matias de. SARC-F is a predictor of longer LOS and hospital readmission in hospitalized patients after a cardiovascular event. Nutrients, [S.l.], v. 14, p. 3154, 30 jul. 2022. DOI: https://doi.org/10.3390/nu14153154. Disponível em: https://www.mdpi.com/2072-6643/14/15/3154. Acesso em: 14 nov.2023. | pt_BR |
| dc.identifier.doi | https://doi.org/10.3390/nu14153154 | |
| dc.identifier.uri | https://repositorio.ufrn.br/handle/123456789/55488 | |
| dc.language | en | pt_BR |
| dc.publisher | Nutrients | pt_BR |
| dc.rights | Attribution 3.0 Brazil | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/br/ | * |
| dc.subject | Sarcopenia | pt_BR |
| dc.subject | cardiovascular disease | pt_BR |
| dc.subject | acute myocardium infarction | pt_BR |
| dc.title | SARC-F is a predictor of longer LOS and hospital readmission in hospitalized patients after a cardiovascular event | pt_BR |
| dc.type | article | pt_BR |
Arquivos
Pacote Original
1 - 1 de 1
Nenhuma Miniatura disponível
- Nome:
- SARC-FPredictorLongerLOS_Fayh_2022.pdf
- Tamanho:
- 750.79 KB
- Formato:
- Adobe Portable Document Format
Nenhuma Miniatura disponível
Licença do Pacote
1 - 1 de 1
Nenhuma Miniatura disponível
- Nome:
- license.txt
- Tamanho:
- 1.45 KB
- Formato:
- Item-specific license agreed upon to submission
Nenhuma Miniatura disponível